Dr. Anna Meseguer, head of the Kidney Physiopathology group at the Vall d’Hebron Institute of Research (VHIR), has received the 2016 Research Grant for Immunotherapy in Kidney Cancer of the American Association for Cancer Research, endowed with...
Read moreTaking care of your kidneys, and also of the youngest ones’
Renal disease, those that affect the kidneys are not an issue just for adults. Younger children also suffer. A reality that sometimes is hidden and has led to devote this year’s World Kidney Day to preventing diseases that affect children...
Read moreDr Simó Schwartz Jr is appointed editor of the European Journal of Nanomedicine
Dr Simó Schwartz Jr, director of the CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VHIR), has been appointed member of the editorial board of the European Journal of Nanomedicine. VHIR’s researcher will review some of the...
Read moreThree VHIR researchers receive three important European grants
Dr. Simó Schwartz Jr, head of the CIBBIM-Nanomedicine Drug Delivery and Targeting group, Dr. Diego Arango, head of the CIBBIM-Nanomedicine Biomedical Research in Digestive Tumors group, and Dr. Mar Hernández-Guillamón, principal investigator of...
Read moreNew methodology to improve the drug response of breast and colon cancer with nanomedicine
Researchers from the Drug Delivery and Targeting group of the CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VIHR), have evidenced that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells. To be...
Read moreVHIR inaugurates the 2nd edition of the Master’s Degree in Translational Biomedical Research
On September 29th, Vall d’Hebron Institute of Research (VHIR) celebrated the opening day of the 2nd edition of the Official Master’s Degree in Translational Biomedical Research and the closing of the 1st edition, with the diploma award ceremony...
Read moreVHIR receives two grants from the AECC to investigate stomach cancer and melanoma
The Vall d’Hebron Research Institute (VHIR) has received two projects in the last call of the Associación Española Contra el Cáncer (AECC) to investigate stomach cancer and malignant melanoma. The projects, worth 1,200,000 euros each, are...
Read moreThe artist Josep Moscardó collaborates with VHIR by donating his Montjuïc Nit work
“Montjuïc nit” is the artist’s Josep Moscardó personal perspective of a set of emblematyc areas of Barcelona such as Montjuïc Hill, the Olympic ring on Montjuïc, the Paral·lel or the Port. Moscardó has donated a silk-screen printing edition...
Read moreVHIR researchers validate a new therapeutic target for colorectal cancer treatment
Researchers from the Group of Molecular Oncology CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VHIR) have validated a gene, called PPOX, as a new therapeutic target against colorectal cancer. Furthermore, this study opens the door...
Read moreVHIR researchers presented the results funded by the Marató of 2009 devoted to rare diseases
On Monday afternoon, 20 research projects funded by La Marató 2009 devoted to rare diseases were presented in the 16th Symposium La Marató of TV3, at the Institut d’Estudis Catalans’ facilities. There were researchers from Vall d’Hebron, who had...
Read moreVHIR proposals for Sant Jordi
Here you have our three recommendations for this Sant Jordi’s Day: ‘En Roc al Planeta Mascareta’, ‘Nano-Oncology, the Turning Point’ and ‘Aians’. These three books are written by professionals from Vall d’Hebron Hospital. En Roc al Planeta...
Read morePossible new strategies to combat epithelial metastatic cancer have been described
An article published by researchers from the School of Pharmacy of the University of Lisbon and from the Molecular Biology and Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine) from the Vall d’Hebron Research Institute...
Read more